Investment Criteria



BlueStone invests in early-stage companies that operate within the Life Sciences. The Fund primarily focuses on companies that reside within five key verticals including: Medical Devices, Advanced Materials, Healthcare IT, Diagnostics, and Biopharma Platforms.

We seek companies that have developed transformative platforms or disruptive technologies, are protected by strong intellectual property, and will have a meaningful impact on healthcare. Our preference is for companies residing in the NATO States (New Mexico, Arizona, Texas, and Oklahoma), however, as a return-driven fund, we will make investments regardless of geography if they fit our “Southwest-like” metrics. 

BlueStone provides growth capital and strategic support to our portfolio companies in addition to privileged access to strategic partners including investors, customers, and other partners residing within the supply chain.